scispace - formally typeset
S

Sally Spendiff

Researcher at Children's Hospital of Eastern Ontario

Publications -  32
Citations -  608

Sally Spendiff is an academic researcher from Children's Hospital of Eastern Ontario. The author has contributed to research in topics: Medicine & Neuromuscular junction. The author has an hindex of 12, co-authored 23 publications receiving 419 citations. Previous affiliations of Sally Spendiff include McGill University Health Centre & Ottawa Hospital.

Papers
More filters
Journal ArticleDOI

Failed reinnervation in aging skeletal muscle

TL;DR: The hypothesis that the accumulation of denervated fibers with aging is due to failed reinnervation and that this may be affected by a limited neurotrophin response that mediates axonal sprouting following denervation is supported.
Journal ArticleDOI

Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle

TL;DR: A novel pattern of chemotherapy-induced mitochondrial dysfunction in skeletal muscle that persists because of an acquired defect in mitophagy signaling is suggested and could explain the observed functional impairments in adult survivors of childhood ALL and may be relevant to long-term survivors of other cancers treated with similar regimes.
Journal ArticleDOI

Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women

TL;DR: It is shown that prefrail/frail elderly women exhibited marked features of muscle denervation, whereas world class octogenarian female master athletes showed attenuated indices of denervation and greater reinnervation capacity.
Journal ArticleDOI

Denervation drives mitochondrial dysfunction in skeletal muscle of octogenarians.

TL;DR: The role of denervation in modulating mitochondrial function in ageing muscle is unknown as mentioned in this paper, however, it has been shown that increased sensitivity to apoptosis initiation occurs prior to evidence of persistent denervation and is thus a primary mitochondrial defect in aging muscle worthy of therapeutic targeting.
Journal ArticleDOI

Reduction in single muscle fiber rate of force development with aging is not attenuated in world class older masters athletes

TL;DR: The slower Vo in both old groups relative to young, coupled with a similarly reduced ktr, suggests impaired cross-bridge kinetics are responsible for impaired single fiber contractile properties with aging, and challenges the widely accepted resilience of slow type fibers to cellular aging.